Select Medical Holdings stock (US81642T1007): investor rights firms scrutinize USD 16.50 take-private offer

Select Medical Holdings shares are trading around the USD 16.50 cash offer from a management-led consortium, while US law firms question whether the proposed take-private terms adequately protect NYSE investors.

Select Medical Holdings stock traded close to the announced cash offer price of USD 16.50 on the New York Stock Exchange on 06/02/2026, as the United States-based operator of specialty hospitals and outpatient rehabilitation clinics moves toward a planned sale to a consortium led by its own executives and directors, according to NYSE pricing data as of 05/28/2026 and recent transaction commentary from Halper Sadeh LLC and other law firms.

US investor-rights firm Halper Sadeh LLC said on 06/02/2026 that it is investigating whether Select Medical Holdings shareholders are receiving a fair price in the pending management-led acquisition at USD 16.50 per share in cash, noting that the transaction would eliminate all public holdings of Select Medical stock when completed, except for rollover interests held by members of the buying group, according to a 06/02/2026 press release carried by PR Newswire and related materials from Halper Sadeh LLC.

The law firm highlighted that it is assessing potential breaches of fiduciary duty by the Select Medical board of directors in connection with the go-private deal, including the adequacy of the sales process, the valuation of the company relative to its prospects, and any potential conflicts of interest arising from participation of senior management and directors on the buy-side, according to the 06/02/2026 notice.

While the company and the buying consortium have framed the proposed cash consideration as a way to provide immediate liquidity and certainty of value to shareholders, the investigations underscore that some NYSE investors and their representatives are evaluating whether USD 16.50 per share fully reflects Select Medical Holdings current operating performance, balance sheet and growth outlook in the US healthcare services market.

According to MarketBeat data referencing 05/28/2026 pricing, Select Medical shares closed at USD 16.50 on 05/28/2026, implying that the average 12-month analyst price target of USD 15.50 and the published high target of USD 16.50 sit around or below the proposed take-private price level, which in turn shapes the legal debate over whether the deal offers an adequate premium to recent trading levels for NYSE investors.

The stock traded at USD 16.50 on 05/28/2026 on the New York Stock Exchange, according to MarketBeat as of 05/28/2026.

As of: 02.06.2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Select Medical Holdings Corporation
• Sector/industry: Healthcare services - specialty hospitals and outpatient rehabilitation
• Headquarters/country: Mechanicsburg, United States
• Core markets: Inpatient rehabilitation hospitals, critical illness recovery hospitals, outpatient physical therapy centers and occupational medicine clinics across the United States
• Key revenue drivers: Patient volumes and reimbursement in specialty hospitals, rehabilitation centers and outpatient clinics, including payor mix from commercial insurers, Medicare and Medicaid
• Home exchange/listing venue: New York Stock Exchange (SEM)
• Trading currency: USD

Select Medical Holdings: core business model

Select Medical Holdings generates revenue mainly by operating a nationwide network of specialty hospitals and rehabilitation-focused outpatient clinics in the United States that treat medically complex patients and provide post-acute and therapy services, with cash flows closely tied to patient throughput and reimbursement levels across its hospital and outpatient segments.

Recent corporate actions

The pending sale of Select Medical Holdings to a management-led consortium for USD 16.50 per share in cash marks a significant potential change in ownership structure, following earlier announcements that the buyer group includes senior executives and directors who intend to roll over a portion of their equity, a factor that is now being examined in detail by US law firms evaluating whether the transaction process and resulting price comply with fiduciary standards for NYSE-listed companies.

Latest quarterly results for Select Medical Holdings at a glance

In its most recently reported quarter, Select Medical Holdings continued to emphasize the performance of its US specialty hospitals and outpatient rehabilitation centers, pointing to trends in patient admissions, length of stay and payer reimbursement as key variables for quarterly revenue and margin development, according to the companys investor materials and filings.

While detailed numbers for the latest quarter are set out in Select Medical Holdings financial reports and related presentations available via its investor relations website, management has repeatedly underscored that growth initiatives in rehabilitation and outpatient care, as well as cost discipline in hospital operations, remain central to quarterly earnings dynamics as the company navigates the transition toward a potential take-private transaction.

Conclusion

The focus for Select Medical Holdings shareholders on the NYSE is currently centered on the proposed USD 16.50 per share cash sale to a management-led consortium and the extent to which this value captures the companys performance and prospects in US post-acute care and outpatient rehabilitation markets.

Ongoing investigations by US investor-rights law firms highlight that some market participants are actively testing the adequacy of the agreed price and the robustness of the boards process, even as Select Medical Holdings continues to operate its nationwide network of specialty hospitals and clinics and report quarterly earnings that inform their assessment of intrinsic value.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.